AstraZeneca’s asthma drug gets regulator’s approval in China
China’s drug regulator, the National Medical Products Association, has approved AstraZeneca Plc’s asthma drug.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
China’s drug regulator, the National Medical Products Association, has approved AstraZeneca Plc’s asthma drug.
The European Medicines Agency has approved Sanofi S.A.’s Dupixent (dupilumab) therapy as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary.
HQ Team May 17, 2024: Johnson & Johnson will acquire Proteologix, Inc., a privately-held biotechnology company, for $850 million in cash, according to.
HQ Team May 4, 2024: A new research says that nitrogen dioxide gas (NO2) emitted by gas and propane stoves is likely to.
Israel’s Teva Pharmaceutical Industries, and US-based Launch Therapeutics, have joined hands to speed up the development of an experimental asthma drug.
HQ Team January 9, 2023: British drugmaker GSK Plc., will pay $1.4 billion to acquire Anglo-American biopharmaceutical company Aiolos Bio Inc., which makes.
HQ Team August 13, 2023: Global air pollution can aid antibiotic resistance in humans, researchers from China and the UK found. They checked.
Lupin buys two inhalation brands for $75million